• A fundraising led and conducted by the American investment company Viscogliosi Brothers, LLC, specialized in the financing of disruptive therapeutic innovations in spine, orthopedics, and healthcare with the co-investment of a leading global medical technology company.
• This fundraising will be used to accelerate the strategic development of Companion Spine, the world’s first pure player specialized in back pain treatment exclusively through spinal joint functional motion preservation, early diagnostic and interventional surgery solutions for the treatment of degenerative disc disease and lumbar spinal stenosis; two of the world’s most common spinal conditions, with more than 10 million potential cases every year in the United States alone.
